Evaluating the efficacy of memantine on improving cognitive functions in epileptic patients receiving anti-epileptic drugs: A double-blind placebo-controlled clinical trial (Phase IIIb pilot study)

OBJECTIVES: People with epilepsy have greater cognitive and behavioral dysfunction than the general population. There is no specific treatment available for cognitive impairment of these patients. We aimed to evaluate the effects of memantine, an N-methyl-D-aspartate-type glutamate receptor noncompe...

Descripción completa

Detalles Bibliográficos
Autores principales: Marimuthu, Priya, Varadarajan, Sathyanarayanan, Krishnan, Muthuraj, Shanmugam, Sundar, Kunjuraman, Gireesh, Ravinder, Jamuna Rani, Arumugam, Balasubramanian, Alex, Divya, Swaminathan, Porchelvan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980957/
https://www.ncbi.nlm.nih.gov/pubmed/27570386
http://dx.doi.org/10.4103/0972-2327.179971

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4980957/
https://www.ncbi.nlm.nih.gov/pubmed/27570386
http://dx.doi.org/10.4103/0972-2327.179971

Ejemplares similares